Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of ...
Climb Bio, Inc.: Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished ...
Medscape11d
New GLP-1 Data Reinforce CV Benefit
Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...
The Pharma Letter1mon
Ariad Pharmaceuticals
US-based Ariad Pharmaceuticals is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. Ariad is working on new medicines to advance the treatment ...
eLife1y
Regulation of different phases of AMPA receptor intracellular transport by 4.1N and SAP97
We expressed sh-RNAs against 4.1 N or SAP97 or their corresponding control (scramble) and analyzed the trafficking of ARIAD-Tag-GluA1 after the addition of the ligand to release the protein from the ...